About Ameliorate Biotech
Ameliorate Biotech is a company based in Bengaluru (India) founded in 2015 by Binita Shrivastava Tunga and Rashbehari Tunga. Ameliorate Biotech has raised $549.34 thousand across 6 funding rounds from investors including LetsVenture, Padup Ventures and DERBI Foundation. Ameliorate Biotech operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Bengaluru, India
- Founders Binita Shrivastava Tunga, Rashbehari Tunga
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Ameliorate Biotech Private Limited
- Date of Incorporation 20 Oct, 2015
- Jurisdiction Off Kanakapura Road Tataguni, Karnataka, India
-
Annual Revenue
$37.92 K (USD)0as on Mar 31, 2023
-
Net Profit
-$57.43 K (USD)21.27as on Mar 31, 2023
-
EBITDA
-$90.68 K (USD)-30.66as on Mar 31, 2023
-
Total Equity Funding
$549.34 K (USD)
in 6 rounds
-
Latest Funding Round
$128.28 K (USD), Seed
Mar 19, 2021
-
Investors
LetsVenture
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Ameliorate Biotech
Unlock access to complete
Unlock access to complete
Funding Insights of Ameliorate Biotech
Ameliorate Biotech has successfully raised a total of $549.34K across 6 strategic funding rounds. The most recent funding activity was a Seed round of $128.28 thousand completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ameliorate Biotech
Ameliorate Biotech has secured backing from 11 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include LetsVenture, Padup Ventures and DERBI Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Empowering tech startups through funding and support services.
|
Locked | Locked | Locked | |
|
Support for innovation and entrepreneurship through incubation programs in Bangalore.
|
Locked | Locked | Locked | |
|
Sector-agnostic startups are accelerated by SINE, backed by IIT Bombay.
|
Locked | Locked | Locked |
Investor details for Ameliorate Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ameliorate Biotech
Investment portfolio details for Ameliorate Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ameliorate Biotech
Detailed financials for Ameliorate Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ameliorate Biotech Comparisons
Peer comparison for Ameliorate Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ameliorate Biotech
Ameliorate Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Ameliorate Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ameliorate Biotech
Complete news archive for Ameliorate Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ameliorate Biotech
Ameliorate Biotech was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Ameliorate Biotech is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Rashbehari Tunga is the current CEO of Ameliorate Biotech. They have also founded this company.
Ameliorate Biotech is a funded company, having raised a total of $549.34K across 6 funding rounds to date.
Annual revenue of Ameliorate Biotech is $37.92K as on Mar 31, 2023.
Ameliorate Biotech was founded in 2015 in Bengaluru, India, within the biotechnology sector. Recombinant therapeutic proteins and diagnostic kits are produced using an antibiotic-free process. Biosimilar products are being developed to address treatments in oncology, autoimmune diseases, ophthalmology, and nephrology. Operations focus on advancing therapeutic solutions through recombinant technology.
Ameliorate Biotech's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Ameliorate Biotech has 11 investors. Key investors include LetsVenture, Padup Ventures, DERBI Foundation, Startup Karnataka, and SINE.
The valuation of Ameliorate Biotech is $1.65M as of Mar 2021.